Programme 2025

Wednesday 22nd January 2025

SESSION: BEHIND THE CLINICAL TRANSPLANT SCENE - FRAMEWORK AND POLICIES

Moderator: Michiel Erasmus and Young Investigator

(20 min talk and 10 min Q&A)

16.00 - 16.30

Eliminating inequities in access to advanced heart failure therapies - past, present and future,

Anna Meyer
Heidelberg University Hospital, Heidelberg, Germany

16.30 - 17.00

Cost effectiveness of VAD in Europe - invisible barriers?

Filip Zemrak
Barts, London, UK

17.00 - 17.30

Review of the anatomy of the lawsuit that changed the allocation policy in 2017

Josh Sonett
Colombia University, New York, USA

17.30 - 18.00

Coffee Break


SESSION: FASCINATING FAILURES AND SURPRISING SUCCESSES

Moderator: Margaret Hannan and Young Investigator

(10 min talk and 5 min Q&A)

18.00 - 18.15
Hyperammonemia following lung transplantation in a patient with primary ciliary dyskinesia

Adbul-Rahman Elhassan
National University - Sudan, Khartoum, Sudan

18.15 - 18.30
A beautiful beast in lung transplantation

Anja Roden
Mayo clinic, Rochester, USA

18.30 - 18.45
EXCOR Berlin Heart as bridge to recovery in adult with immediate graft failure post-transplant

Kevin Brennan
Freeman Hospital, Newcastle upon Tyne, UK

18.45 - 19.00
an 'out of the box' lung transplant on a patient with a giant pulmonalis

Theo Klinkenberg,
University Medical Center Groningen, Groningen, the Netherlands

19.00 - 19.15
Successful long term PAH targeted treatment effect or failure in optimal timing for lung-transplantation in a young severe APAH-ACHD patient - following WSPH

G - ran R - degran
Skane University Hospital, Lund, Sweden

19.15 - 19.30
Heart transplantation in situs inversus with dextrocardia

Ronny Gustafsson
Lund University Hospital, Lund, Sweden

Thursday 23rd January 2025

SESSION: NOVEL TECHNIQUES IN THE TRANSPLANT JOURNEY

Moderator: Louise Kenny and Young Investigator

(15 min talk and 5 min Q&A)

16.00 - 16.20

Future developments in left ventricular assist devices

Martin Strueber,
Baptist Medical Group, Memphis, Tennessee

16.20 - 16.40

Novel biomarkers to evaluate organ preservation and rejection

Jesper Magnusson,
Sahlgrenska University Hospital, Gothenburg, Sweden

16.40 - 17.00

Partial Heart Transplantation - new option, new needs?

Joseph Turek,
Duke University Medical Center, Durham, North Carolina, USA

17.00 - 17.30

Business Meeting

17.30 - 18.00

Coffee break

SESSION: PULMONARY HYPERTENSION AND THE RIGHT HEART

Moderator: Erik Verschuuren and Young Investigator

(15 min talk and 5 min Q&A)

18.00 - 18.20

PAH & Transplant selection - Getting it right or is it ever possible?

Arun Nair,
Freeman Hospital, Newcastle upon Tyne, UK

18.20 - 18.40

A single cannula RAVA-ECMO - a novel solution for PH patients as bridge to lung transplant

Yaron Barac,
Rabin Medical Center, Petach-Tikva, Israel

18.40 - 19.00

Primary isolated right heart failure post-heart transplantation - how to improve outcomes?

Sven-Erik Bartfay,
Sahlgrenska University Hospital, Gothenburg, Sweden

19.00 - 19.30

Session: WERNER ZUBER MEMORIAL LECTURE

Introduction: Paul Corris

19.00 - 19.30
How low- and highlanders cope with high altitude: varying hemoglobin levels worldwide

Max Gassmann
University of Zurich, Zurich, Switzerland

Friday 24th January 2025

SESSION: ORGAN RECOVERY AND PERFUSION

Moderator: Lars Nolke and Young Investigator

(20 min talk and 10 min Q&A)

16.00 - 16.30

Removing the resource burden form the lung transplant centres - centralizing EVLP in Europe

Hasse M - ller-S - rensen,
Rigshospitalet, Copenhagen, Denmark

16.30 - 17.00

Hypothermic Oxygenated PErfusion of the heart: HOPE for children

Louise Kenny,
Freeman Hospital, Newcastle upon Tyne, UK

17.00 - 17.30

DCD lung transplantation in children

Glen Westall,
Alfred Hospital, Melbourne, Australia

SESSION - OPEN DEBATE

Moderator: Clive Lewis

17.30 - 18.00

Heart and/or lung transplant should be offered to -

Selim Arcasoy
Colombia University, New York, USA

Ivan Knezevic,
University Medical Centre, Ljubljana, Slovenia

18.00 - 18.20

Coffee break

18.30 - 19.30

Session: Young Investigators Award

(8 min. talk and 2 min Q&A)

Moderator: Michael Perch

18.20 - 18.30
Prolonged ex situ oxygenated hypothermic machine preservation in donation after circulatory death donor hearts

Imran Ertegrul, Groningen, The Netherlands

18.30 - 18.40Strategies for incorporating recipients - clinical urgency into donor heart allocation policies - an international comparison

William Jenner, Papworth, UK

18.40 - 18.50
Ex Vivo Optimization of Donor Lungs with Inhaled Sevoflurane during Normothermic Ex Vivo Lung Perfusion (VITALISE)

Shuqi Yang, Groningen, The Netherlands

18.50 - 19.00
Ketone body 3-hydroxybutyrate improves myocardial mitochondrial respiratory function during Heart Transplantation

Klaes Van Lenbroch, Aarhus, Denmark

19.00 - 19.10
The Impact of Time to Death on Donation after Circulatory Death Lung Transplant Outcomes

Nicholas Chilvers, Newcastle, UK

19.10 - 19.20
Biomarkers of Standard Criteria and Marginal Donor Lungs During Ex Vivo Lung Perfusion: A Comparative Study

Michiel Hu, Groningen, The Netherlands

19.10 - 19.20
Hypothermic Oxygenated Perfusion and Static Cold Storage Induce Significant Transcriptomic Changes in Porcine Hearts with Minimal Variation between Preservation Methods

Elisa Ballan, Utrecht, The Netherlands